Golden
Mission Bay Capital

Mission Bay Capital

Mission Bay Capital is a venture capital firm investing in early stage biotechnology and life science companies. It is headquartered in San Francisco and was founded in 2009 by the California Institute of Quantitative Biosciences.

The California Institute of Quantitative Biosciences (QB3) founded Mission Bay Capital in 2009 to provide venture capital to startups at the University of California. Mission Bay Capital is a venture capital firm making seed and early stage investments in startup technology companies typically operating within the industries of biotechnology and life science. The firms head office is located in San Francisco, California. Notable exits made by Mission Bay Capital include: Calithera Biosciences, iPierian, Redwood Bioscience, and Zephyrus Biosciences. 

Timeline

Funded Companies

6 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Wild Type is a San Francisco based company producing meat products like salmon using cellular agriculture lab techniques.

Alector is a San Francisco-based biotechnology company.

ViewPoint Therapeutics is a San Francisco-based company.

SiteOne Therapeutics is a Bozeman, Montana-based company.

Pionyr Immunotherapeutics is a San Francisco-based company.

Associated investment funds

3 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed
25,000,000
25,000,000
May 2, 2015
15,000,000
6,053,873
September 1, 2009
85,000,000
26,271,034
August 8, 2018

People

Name
Role
LinkedIn

Brian Atwood

Investment Committee



Brook Byers

Investment Committee



Chris Christoffersen

Investment Committee



Douglas Crawford

Managing Director



Fred Cohen

Investment Committee



Harold E. Selick

Venture Partner



John Wadsworth, Jr

Investment Committee



Jonathan Root

Investment Committee



Linda Eng

Office Manager



Luke Evnin

Investment Committee



Peter D. Parker

Managing General Partner



Regis Kelly

Senior Advisor



Robert Blazej

Partner



Vivian Dang

Controller



Wende Hutton

Investment Committee



Further reading

Title
Author
Link
Type
Date

Mission Bay Capital Fund Launches - PE Hub

OEHub Administrator

Web



Mission Bay Capital Raising $85 Million for Life Science Startups

Heather Mack

Web



Small but mighty VC doubles up with new biotech seed fund

Ron Leuty

Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Alector 





Genomics/Medical





Medical





Agriculture

Atreca





Medical/Immunotherapy

Avexegen 





Medical/Gastrointestinal Disorders





Genomics





Fashion/Cellular Agriculture/Biotechnology





Genomics





Biotechnology





Medical/Neurological Disorders





Drug Development

Droplet 





Health Monitoring





Genomics/Medical

Epiodyne 





Medical





Medical/Drug Discovery





Health Monitoring





Histology





Health Monitoring

MagNap 





Medical





Disease Detection

Mitokinin





Medical

Perlara 





Drug Discovery





Scientific Research Tools





Drug Discovery





Biopharmaceuticals

References